Back to top

Image: Bigstock

CryoPort, Inc. (CYRX) Stock Jumps 10.5%: Will It Continue to Soar?

Read MoreHide Full Article

CryoPort, Inc. (CYRX - Free Report) shares rallied 10.5% in the last trading session to close at $29.08. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 8.9% gain over the past four weeks.

This logistics operator, which provides service to other celllular therapy innovators, is being well-served by its growth-by-acquisition approach. The recent deal with Takeda also bodes well. Shares of CYRX  have gained 17.3% over the past month.

This company is expected to post quarterly loss of $0.13 per share in its upcoming report, which represents a year-over-year change of +27.8%. Revenues are expected to be $70.22 million, up 23.9% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For CryoPort, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CYRX going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

CryoPort, Inc. is a member of the Zacks Transportation - Services industry. One other stock in the same industry, Matson (MATX - Free Report) , finished the last trading session 0.9% higher at $73.22. MATX has returned 15% over the past month.

For Matson, the consensus EPS estimate for the upcoming report has changed -2.9% over the past month to $6.75. This represents a change of +3.4% from what the company reported a year ago. Matson currently has a Zacks Rank of #3 (Hold).

See More Zacks Research for These Tickers

Normally $25 each - click below to receive one report FREE:

CryoPort, Inc. (CYRX) - free report >>

Matson, Inc. (MATX) - free report >>

Published in